Moderna: Award to Support Late-Stage Development to Enable Licensure of Pre-Pandemic Vaccine Against H5 Influenza Virus
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.